【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Prostate Cancer Market, By Type
5.1 Introduction
5.2 Hormone Sensitive
5.3 Hormone Refractory
6 Global Prostate Cancer Market, By Therapy
6.1 Introduction
6.2 Focal Therapies
6.3 Biologic Therapy
6.4 Cryosurgery
6.5 Immunotherapy
6.5.1 Vaccines
6.6 Therapeutic Vaccines
6.6.1 Provenge (Sipuleucel-T)
6.7 Radiation Therapy
6.7.1 External Beam
6.7.1.1 Stereotactic Body
6.7.1.2 Proton Beam
6.7.1.3 Intensity Modulated
6.7.1.4 3D Conformal
6.7.2 Brachytherapy
6.7.2.1 Temporary
6.7.2.2 Permanent
6.8 Chemotherapy
6.8.1 Vinorelbine
6.8.2 Vinblastine
6.8.3 Taxotere (Docetaxel)
6.8.4 Taxanes
6.8.5 Jevtana (Cabazitaxel)
6.8.6 Etoposide
6.8.7 Cytotoxic Drugs
6.8.8 Carboplatin
6.8.9 Antimetabolites
6.8.10 Anthracyclines
6.8.11 Alkylating Agents
6.9 Surgery
6.9.1 Trans Urethral Resection (TUR)
6.9.2 Radical Prostatectomy
6.9.3 Orchidectomy
6.10 Targeted Therapy
6.10.1 Tyrosine Kinase Inhibitors
6.10.2 Signal Transduction Inhibitor
6.10.3 Monoclonal Antibodies
6.10.4 Apoptosis Inducing Drugs
6.10.5 Angiogenesis Inhibitor
6.11 Bone Metastasis
6.11.1 Zometa (Zoledronic Acid)
6.11.2 Xofigo (Radium 223 Dichloride)
6.11.3 Xgeva (Denosumab)
6.11.4 Alpharadin
6.12 Hormonal Therapy
6.12.1 Aromatase Inhibitors
6.12.2 Estrogen-Receptor Modulators (Serms)
6.12.3 Luteinizing Hormone–Releasing Hormone (LHRH) Analogs
6.12.3.1 Lupron
6.12.3.2 Zoladex
6.12.3.3 Decapeptyl
6.12.3.4 Eligard
6.12.3.5 Vantas
6.12.3.6 Leuplin
6.12.3.7 Trelstar (Triptorelin Pamoate)
6.12.3.8 Firmagon (Degarelix)
6.12.3.9 Casodex (Bicalutamide)
6.12.4 Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists
6.12.4.1 Zytiga
6.12.4.2 Gonax
6.12.4.3 Xtandi (Enzalutamide)
6.12.5 Anti–Androgens
6.12.5.1 Casodex
6.12.5.2 Xtandi or MDV3100
6.12.5.3 Xtandi US or MDV3100
6.12.6 Other Hormonal Therapies
7 Global Prostate Cancer Market, By Diagnostic Technique
7.1 Introduction
7.2 Prostate Specific Antigen Test (PSA)
7.3 Digital Rectal Exam (DRE)
8 Global Prostate Cancer Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Pharmacies
8.5 Specialty Clinics
8.6 Other End Users
9 Global Prostate Cancer Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Astellas, Inc.
11.2 AstraZeneca plc
11.3 Bristol Myers Squibb (BMS)
11.4 Johnson & Johnson
11.5 NOVARTIS
11.6 Sanofi S.A
11.7 TOLMAR Inc.
11.8 Tokai Pharmaceuticals
11.9 Progenics Pharmaceuticals Inc.
11.10 OncoGenex Pharmaceuticals Inc.
11.11 OncBioMune Pharmaceuticals Inc.
11.12 Endo Pharmaceuticals
11.13 Bayer Pharma AG
List of Tables
Table 1 Global Prostate Cancer Market Outlook, By Region (2016-2026) (US $MN)
Table 2 Global Prostate Cancer Market Outlook, By Type (2016-2026) (US $MN)
Table 3 Global Prostate Cancer Market Outlook, By Hormone Sensitive (2016-2026) (US $MN)
Table 4 Global Prostate Cancer Market Outlook, By Hormone Refractory (2016-2026) (US $MN)
Table 5 Global Prostate Cancer Market Outlook, By Therapy (2016-2026) (US $MN)
Table 6 Global Prostate Cancer Market Outlook, By Focal Therapies (2016-2026) (US $MN)
Table 7 Global Prostate Cancer Market Outlook, By Biologic Therapy (2016-2026) (US $MN)
Table 8 Global Prostate Cancer Market Outlook, By Cryosurgery (2016-2026) (US $MN)
Table 9 Global Prostate Cancer Market Outlook, By Immunotherapy (2016-2026) (US $MN)
Table 10 Global Prostate Cancer Market Outlook, By Vaccines (2016-2026) (US $MN)
Table 11 Global Prostate Cancer Market Outlook, By Therapeutic Vaccines (2016-2026) (US $MN)
Table 12 Global Prostate Cancer Market Outlook, By Provenge (Sipuleucel-T) (2016-2026) (US $MN)
Table 13 Global Prostate Cancer Market Outlook, By Radiation Therapy (2016-2026) (US $MN)
Table 14 Global Prostate Cancer Market Outlook, By External Beam (2016-2026) (US $MN)
Table 15 Global Prostate Cancer Market Outlook, By Brachytherapy (2016-2026) (US $MN)
Table 16 Global Prostate Cancer Market Outlook, By Chemotherapy (2016-2026) (US $MN)
Table 17 Global Prostate Cancer Market Outlook, By Vinorelbine (2016-2026) (US $MN)
Table 18 Global Prostate Cancer Market Outlook, By Vinblastine (2016-2026) (US $MN)
Table 19 Global Prostate Cancer Market Outlook, By Taxotere (Docetaxel) (2016-2026) (US $MN)
Table 20 Global Prostate Cancer Market Outlook, By Taxanes (2016-2026) (US $MN)
Table 21 Global Prostate Cancer Market Outlook, By Jevtana (Cabazitaxel) (2016-2026) (US $MN)
Table 22 Global Prostate Cancer Market Outlook, By Etoposide (2016-2026) (US $MN)
Table 23 Global Prostate Cancer Market Outlook, By Cytotoxic Drugs (2016-2026) (US $MN)
Table 24 Global Prostate Cancer Market Outlook, By Carboplatin (2016-2026) (US $MN)
Table 25 Global Prostate Cancer Market Outlook, By Antimetabolites (2016-2026) (US $MN)
Table 26 Global Prostate Cancer Market Outlook, By Anthracyclines (2016-2026) (US $MN)
Table 27 Global Prostate Cancer Market Outlook, By Alkylating Agents (2016-2026) (US $MN)
Table 28 Global Prostate Cancer Market Outlook, By Surgery (2016-2026) (US $MN)
Table 29 Global Prostate Cancer Market Outlook, By Trans Urethral Resection (TUR) (2016-2026) (US $MN)
Table 30 Global Prostate Cancer Market Outlook, By Radical Prostatectomy (2016-2026) (US $MN)
Table 31 Global Prostate Cancer Market Outlook, By Orchidectomy (2016-2026) (US $MN)
Table 32 Global Prostate Cancer Market Outlook, By Targeted Therapy (2016-2026) (US $MN)
Table 33 Global Prostate Cancer Market Outlook, By Tyrosine Kinase Inhibitors (2016-2026) (US $MN)
Table 34 Global Prostate Cancer Market Outlook, By Signal Transduction Inhibitor (2016-2026) (US $MN)
Table 35 Global Prostate Cancer Market Outlook, By Monoclonal Antibodies (2016-2026) (US $MN)
Table 36 Global Prostate Cancer Market Outlook, By Apoptosis Inducing Drugs (2016-2026) (US $MN)
Table 37 Global Prostate Cancer Market Outlook, By Angiogenesis Inhibitor (2016-2026) (US $MN)
Table 38 Global Prostate Cancer Market Outlook, By Bone Metastasis (2016-2026) (US $MN)
Table 39 Global Prostate Cancer Market Outlook, By Zometa (Zoledronic Acid) (2016-2026) (US $MN)
Table 40 Global Prostate Cancer Market Outlook, By Xofigo (Radium 223 Dichloride) (2016-2026) (US $MN)
Table 41 Global Prostate Cancer Market Outlook, By Xgeva (Denosumab) (2016-2026) (US $MN)
Table 42 Global Prostate Cancer Market Outlook, By Alpharadin (2016-2026) (US $MN)
Table 43 Global Prostate Cancer Market Outlook, By Hormonal Therapy (2016-2026) (US $MN)
Table 44 Global Prostate Cancer Market Outlook, By Aromatase Inhibitors (2016-2026) (US $MN)
Table 45 Global Prostate Cancer Market Outlook, By Estrogen-Receptor Modulators (Serms) (2016-2026) (US $MN)
Table 46 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Analogs (2016-2026) (US $MN)
Table 47 Global Prostate Cancer Market Outlook, By Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists (2016-2026) (US $MN)
Table 48 Global Prostate Cancer Market Outlook, By Anti–Androgens (2016-2026) (US $MN)
Table 49 Global Prostate Cancer Market Outlook, By Other Hormonal Therapies (2016-2026) (US $MN)
Table 50 Global Prostate Cancer Market Outlook, By Diagnostic Technique (2016-2026) (US $MN)
Table 51 Global Prostate Cancer Market Outlook, By Prostate Specific Antigen Test (PSA) (2016-2026) (US $MN)
Table 52 Global Prostate Cancer Market Outlook, By Digital Rectal Exam (DRE) (2016-2026) (US $MN)
Table 53 Global Prostate Cancer Market Outlook, By End User (2016-2026) (US $MN)
Table 54 Global Prostate Cancer Market Outlook, By Ambulatory Surgical Centers (2016-2026) (US $MN)
Table 55 Global Prostate Cancer Market Outlook, By Hospitals (2016-2026) (US $MN)
Table 56 Global Prostate Cancer Market Outlook, By Pharmacies (2016-2026) (US $MN)
Table 57 Global Prostate Cancer Market Outlook, By Specialty Clinics (2016-2026) (US $MN)
Table 58 Global Prostate Cancer Market Outlook, By Other End Users (2016-2026) (US $MN)
NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.
【レポート販売概要】
■ タイトル：前立腺がんの世界市場展望2017-20276■ 英文：Prostate Cancer - Global Market Outlook (2017-2026)
■ 発行日：2019年8月
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC20FB306
■ 調査対象地域：グローバル
- 世界のアジピン酸市場動向（～2019）The report covers the adipic acid market on the basis of material type, applications, and geography. The market data for these types is given with respect to volume (thousand tons) and value ($Million). The market value of adipic acid was estimated to be $5,884.6 million in 2012, and is projected to grow with a CAGR of 3.7% from 2014 to 2019. The data mentioned in the report are based on the globa …
- TD-LTE市場動向 : 世界主要国の導入状況と課題The TD-LTE ecosystem is still in its early days but the commercial launch by China Mobile in December 2013 is going to boost the TD-LTE market. Our estimates for TD-LTE subscriptions in December 2013, based on the data from our LTE Watch service, indicate fewer than 3.5 million subscriptions. This report presents the TD-LTE deployment status in the main markets (Japan, USA, China, Australia, India …
- 世界における小型自動車用燃料噴射装置市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE fuel injection sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE fuel injection market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and p …
- 世界の塗料市場2015：展望、戦略、技術The report provides a worldwide strategic overview of the paints and coatings market, including:• Sales forecasts for major market segments.• Sales forecasts for key geographic regions: North America, Europe, Asia Pacific, Latin America, Africa, Mideast.In addition, the report reviews the major U.S. and international regulatory, technological, economic, demographic, and social trends wit …
- カポジ肉腫(Kaposi’s Sarcoma)の治療薬パイプライン動向（2015年上半期版）Kaposi's Sarcoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Kaposi's Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Kaposi's Sarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of …
- 世界の電力産業におけるDCS（分散制御システム）市場About DCS A DCS is an automated control system that, rather than being centralized, is distributed across an entire organization. DCS is distributed in such a way that each component or sub-system of a manufacturing plant is controlled by one or more controllers, thereby providing instructions to different parts of the plant. Thus, instead of having a centrally located control system, each section …
- ガスクロマトグラフィーの世界市場2017-2021About Gas Chromatograph Chromatography refers to a set of laboratory techniques used for the separation of mixtures. It involves a mobile phase and a stationary phase. The mixture is dissolved in the mobile phase, which is then passed to the stationary phase. The separation of the mixture is caused by the different speeds at which the various constituents of the mixture travel. The separation of t …
- 家庭用真空掃除機の世界市場2017-2021About Household Vacuum CleanerVacuum cleaners are electrical appliances that use an air pump to suck up dirt and dust from floors and other surfaces. The dust is secured in a dust bag that can be emptied later. Different types of vacuum cleaners are available depending on the type of surface to be cleaned. Vacuum cleaners clean surfaces with ease over a short time. Technavio’s analysts forecast th …
- 中国の麻酔装置・呼吸装置市場China Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "China Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management …
- 食品産業用パルス電場（PEF）システムの世界市場2020-2024Global Food Industry Pulsed Electric Field (PEF) Systems Market 2020-2024 Technavio has been monitoring the food industry pulsed electric field (PEF) systems market and it is poised to grow by USD 227.52 mn during 2020-2024, progressing at a CAGR of 24% during the forecast period. Our reports on food industry pulsed electric field (PEF) systems market provides a holistic analysis, market size and …
- オンライン広告支出の世界市場About Online Ad Spending Online advertising involves the marketing and promotion of products, services, or brand by using internet as a medium. Online ad spending is the total amount of money an organization invests to promote its products, services, or brand online. The increasing use of internet has made companies realize the importance of online advertisements to attract and drive their target …
- 腫瘍用バイオ後続品の世界市場：がん治療薬、支持療法用薬About Oncology Biosimilars Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting. Biosimilars are synthesized with the use of biologic components …
- 世界の整形外科用バイオマテリアル（生体材料）市場：移植骨、機械加工骨、DBM、BMP（骨形成タンパク質)などAbout Orthopedic Biomaterial Orthopedic biomaterial deals with the physical and chemical properties of the material that is implanted into the human body as constituents of devices. The material implanted is designed to perform specific biological functions by substituting or repairing the damaged tissues such as cartilage, bone, ligaments, and tendons. Bone and joint-related degenerative problems …
- 統合ネットワーク管理の世界市場：有線、無線The unified network management market is estimated to grow from USD 5.01 Billion in 2016 to USD 12.32 Billion by 2021. The market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) of 19.7% owing to the rising usage of unified networking solutions among organizations to manage and control wireline or wireless networking activities. Companies are deploying unified networking so …
- 世界のファイナンス及び会計BPO市場動向（2012-2016）TechNavio's analysts forecast the Global Finance and Accounting BPO market to grow at a CAGR of 8.04 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing focus of enterprises on core competencies. The Global Finance and Accounting BPO market has also been witnessing the increasing focus of vendors in the mid-market. However, the lack of dom …
